Navigation Links
Niutang Sucralose Patent Litigation Successfully Concluded
Date:6/1/2009

Tate & Lyle will not appeal ITC decision; Voluntarily dismisses District Court case

BREA, Calif., June 1 /PRNewswire/ -- Changzhou Niutang, one of the largest global manufacturers of sucralose, and its U.S. subsidiary, US Niutang, today announced that Tate & Lyle will not appeal the recent decision made by the U.S. International Trade Commission that decisively rejected Tate & Lyle's infringement allegations against Niutang. In addition, Tate & Lyle has requested a voluntary dismissal of the patent infringement allegations it brought against Niutang in the United States District Court.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090528/CG23830LOGO)

"We are delighted to have all aspects of this litigation successfully concluded, with a complete victory in favor of Niutang," said Licheng Wang Jr., General Manager of Changzhou Niutang. "We will continue to focus our attention on what we do best - providing the highest quality sweeteners and food additives along with outstanding service to our worldwide customers."

Niutang has steadily grown its sucralose customer base, which now spans North America, Central America, South America, Europe and Asia. Niutang is already one of the largest manufacturers of aspartame in the world, and it has built upon that successful track record in growing its sucralose business.

"Niutang's sucralose sales have more than tripled from 2007 to 2008," continued Wang. "We recently completed the expansion of our sucralose capacity to 300 metric tons and have announced our plans to increase our capacity to 500 metric tons by 2012. As our sucralose business continues to grow, we remain committed to providing our customers with the high-quality products and unsurpassed level of customer service they have come to expect from Niutang."

Niutang is one of the largest and most experienced global manufacturers of sucralose. The company's established track record is built upon the highest standards of quality control, with products that are:

  • Manufactured according to cGMP requirements as stated in CFR 21 Part 110
  • Produced to meet all quality specifications required by current FCC
  • Moody International ISO 9001:2000/cGMP/HACCP certified
  • Kosher and Halal certified
  • Registered with the U.S. FDA in accordance with the Security and Bioterrorism Preparedness and Response Act of 2002

About Niutang

Niutang Chemical is one of the world's leading manufacturers and distributors of food additives, chemicals and pharmaceutical intermediates that are instrumental to food, beverage, pharmaceutical, nutraceutical and industrial products. Established in 1969, Niutang's commitment to producing the highest quality food additives at competitive prices has ensured its rapid growth into a leading global manufacturer of aspartame, folic acid, and more recently, sucralose. The company is certified in meeting the most stringent U.S. and European manufacturing, compliance and quality benchmarks. Based in China, Niutang also has sales and quality control operations in the United States and Europe that support its strong reputation for integrity and customer service. The company's website is www.niutang.com. For inquiries regarding Niutang Sucralose sales, please contact sales@niutang.us.

    For more information:

    Doreen Lubeck
    DJ Lubeck, LLC
    773-583-4331
    djlubeck@yahoo.com


'/>"/>
SOURCE Niutang Chemical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Niutang to Expand Sucralose Capacity 66 Percent by 2012
2. Niutang Recruits Seasoned Executive to Open U.K. Office
3. GDFII/L&P Sucralose Win Over Competitor Tate & Lyle
4. SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER
5. Falcon Genomics Awarded Patent for Innovative Cancer Test
6. Viral Genetics Has Option Under Issued Key Patent for Cancer Drug
7. CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)
8. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
9. Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force
10. Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence
11. Palomar Wins Two European Hair Removal Patent Opposition Hearings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... The president released a FY 2017 budget request ... shift more of the cost burden to military beneficiaries. , MOAA’s president, retired ... defense budget as including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. ...
(Date:2/11/2016)... ... 2016 , ... In a new paper published in the ... Rod J. Rohrich, and colleagues, examine and underscore the importance of upper lateral ... when addressing this vital area. , The upper lateral cartilage in rhinoplasty, refers ...
(Date:2/11/2016)... ... February 11, 2016 , ... PharmMD CEO Robert ... will focus on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities ... practices in data breaches for the Part D Star Rating improvement and Medication ...
(Date:2/11/2016)... ... February 11, 2016 , ... Talix today announced ... , will be presenting at the 2016 HIMSS Annual Conference & Exhibition, taking ... During his session, “ Coding for Care: Using Data Analytics for Risk Adjustment ...
(Date:2/11/2016)... ... February 11, 2016 , ... Be Well Medical ... in the heart of Old Town at 108 South Columbus St, Suite 201, Alexandria, ... highest level of medical care in the convenience of their homes, offices or at ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 Transformational M&A achieved through NPS ... --> Transformational M&A achieved through NPS and Dyax ... Transformational M&A achieved through NPS and Dyax acquisitions ... for future growth with most robust pipeline in Shire ... future growth with most robust pipeline in Shire , ...
(Date:2/11/2016)... 11, 2016  AbbVie, a global biopharmaceutical company, ... designed to provide financial support for exceptional students ... higher education goals. Fifteen scholars will be selected ... year. The AbbVie Rheumatology Scholarship is currently accepting ... president, corporate social responsibility, brand and communications, AbbVie. ...
(Date:2/11/2016)... Exactus Pharmacy Solutions, a WellCare (NYSE: ... care for those suffering from long-term, life-threatening or ... Specialty Pharmacy Accreditation from URAC, an independent, nonprofit ... care quality through accreditation, education and measurement. ... URAC accreditation process demonstrates a commitment to quality ...
Breaking Medicine Technology: